180 related articles for article (PubMed ID: 22902520)
1. Long circulating enzyme replacement therapy rescues bone pathology in mucopolysaccharidosis VII murine model.
Rowan DJ; Tomatsu S; Grubb JH; Haupt B; Montaño AM; Oikawa H; Sosa AC; Chen A; Sly WS
Mol Genet Metab; 2012 Sep; 107(1-2):161-72. PubMed ID: 22902520
[TBL] [Abstract][Full Text] [Related]
2. Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII.
Huynh HT; Grubb JH; Vogler C; Sly WS
Proc Natl Acad Sci U S A; 2012 Oct; 109(42):17022-7. PubMed ID: 23027951
[TBL] [Abstract][Full Text] [Related]
3. Chemically modified beta-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII.
Grubb JH; Vogler C; Levy B; Galvin N; Tan Y; Sly WS
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2616-21. PubMed ID: 18268347
[TBL] [Abstract][Full Text] [Related]
4. Vestronidase alfa: Recombinant human β-glucuronidase as an enzyme replacement therapy for MPS VII.
Cadaoas J; Boyle G; Jungles S; Cullen S; Vellard M; Grubb JH; Jurecka A; Sly W; Kakkis E
Mol Genet Metab; 2020 May; 130(1):65-76. PubMed ID: 32192868
[TBL] [Abstract][Full Text] [Related]
5. Infused Fc-tagged beta-glucuronidase crosses the placenta and produces clearance of storage in utero in mucopolysaccharidosis VII mice.
Grubb JH; Vogler C; Tan Y; Shah GN; MacRae AF; Sly WS
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8375-80. PubMed ID: 18544647
[TBL] [Abstract][Full Text] [Related]
6. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs.
Mango RL; Xu L; Sands MS; Vogler C; Seiler G; Schwarz T; Haskins ME; Ponder KP
Mol Genet Metab; 2004 May; 82(1):4-19. PubMed ID: 15110316
[TBL] [Abstract][Full Text] [Related]
7. First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient.
Fox JE; Volpe L; Bullaro J; Kakkis ED; Sly WS
Mol Genet Metab; 2015 Feb; 114(2):203-8. PubMed ID: 25468648
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.
Derrick-Roberts AL; Pyragius CE; Kaidonis XM; Jackson MR; Anson DS; Byers S
Hum Gene Ther; 2014 Sep; 25(9):798-810. PubMed ID: 25003807
[TBL] [Abstract][Full Text] [Related]
9. Enzyme therapy in mannose receptor-null mucopolysaccharidosis VII mice defines roles for the mannose 6-phosphate and mannose receptors.
Sly WS; Vogler C; Grubb JH; Levy B; Galvin N; Tan Y; Nishioka T; Tomatsu S
Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15172-7. PubMed ID: 17015822
[TBL] [Abstract][Full Text] [Related]
10. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
[TBL] [Abstract][Full Text] [Related]
11. Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy.
Vogler C; Levy B; Galvin NJ; Thorpe C; Sands MS; Barker JE; Baty J; Birkenmeier EH; Sly WS
Pediatr Res; 1999 Jun; 45(6):838-44. PubMed ID: 10367775
[TBL] [Abstract][Full Text] [Related]
12. Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival.
Vogler C; Sands MS; Levy B; Galvin N; Birkenmeier EH; Sly WS
Pediatr Res; 1996 Jun; 39(6):1050-4. PubMed ID: 8725268
[TBL] [Abstract][Full Text] [Related]
13. Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation.
Sands MS; Vogler C; Torrey A; Levy B; Gwynn B; Grubb J; Sly WS; Birkenmeier EH
J Clin Invest; 1997 Apr; 99(7):1596-605. PubMed ID: 9120003
[TBL] [Abstract][Full Text] [Related]
14. Skeletal response to lentiviral mediated gene therapy in a mouse model of MPS VII.
Macsai CE; Derrick-Roberts AL; Ding X; Zarrinkalam KH; McIntyre C; Anderson PH; Anson DS; Byers S
Mol Genet Metab; 2012 Jun; 106(2):202-13. PubMed ID: 22525091
[TBL] [Abstract][Full Text] [Related]
15. Enzyme replacement therapy for murine mucopolysaccharidosis type VII.
Sands MS; Vogler C; Kyle JW; Grubb JH; Levy B; Galvin N; Sly WS; Birkenmeier EH
J Clin Invest; 1994 Jun; 93(6):2324-31. PubMed ID: 8200966
[TBL] [Abstract][Full Text] [Related]
16. Enzyme replacement with recombinant beta-glucuronidase in the newborn mucopolysaccharidosis type VII mouse.
Vogler C; Sands M; Higgins A; Levy B; Grubb J; Birkenmeier EH; Sly WS
Pediatr Res; 1993 Dec; 34(6):837-40. PubMed ID: 8108204
[TBL] [Abstract][Full Text] [Related]
17. Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: early treatment rescues bone lesions?
Tomatsu S; Montaño AM; Oikawa H; Dung VC; Hashimoto A; Oguma T; Gutiérrez ML; Takahashi T; Shimada T; Orii T; Sly WS
Mol Genet Metab; 2015 Feb; 114(2):195-202. PubMed ID: 24953405
[TBL] [Abstract][Full Text] [Related]
18. Enzyme replacement therapy improves reproductive performance in mucopolysaccharidosis type VII mice but does not prevent postnatal losses.
Soper BW; Pung AW; Vogler CA; Grubb JH; Sly WS; Barker JE
Pediatr Res; 1999 Feb; 45(2):180-6. PubMed ID: 10022587
[TBL] [Abstract][Full Text] [Related]
19. Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice.
Montaño AM; Oikawa H; Tomatsu S; Nishioka T; Vogler C; Gutierrez MA; Oguma T; Tan Y; Grubb JH; Dung VC; Ohashi A; Miyamoto K; Orii T; Yoneda Y; Sly WS
Mol Genet Metab; 2008 Jun; 94(2):178-89. PubMed ID: 18359257
[TBL] [Abstract][Full Text] [Related]
20. C-Type Natriuretic Peptide Restores Growth Impairment Under Enzyme Replacement in Mice With Mucopolysaccharidosis VII.
Yamashita T; Fujii T; Yamauchi I; Ueda Y; Hirota K; Kanai Y; Yasoda A; Inagaki N
Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31974587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
